Denise M Kalos is the Founder and CEO of AFFIRMATIVhealth, launched in May 2016, bringing a precision medicine approach to improve cognitive health for those affected by Alzheimer's disease and various cognitive disorders.
Recently, Ms. Kalos was Vice President, Cognitive Wellbeing Programs for the Buck Institute for Research on Aging. As a key leader of the Institute's "RE:mind" program, she built the first program globally to utilize personalized medicine providing people customized information and education needed to take control of their cognitive wellbeing. AFFIRMATIVhealth licensed the intellectual property from the Buck Institute for the RE:mind program. Ms. Kalos is currently tasked with scaling a PaaS solution delivering comprehensive, precision treatment options to physicians and their patients living with Alzheimer's disease.
Prior to joining the Buck Insitutue, Ms. Kalos was VP Corporate Solutions for O'Reilly Media and a member of O'Reilly's Steering Committee for this technology futurist company that coined the term, "Web 2.0". Earlier in her career, she was Practice Leader for a strategy consulting firm, C-Change, Inc. and before C-Change, was part of the executive team that brought AMB Properties Corporation "public" in 1997.
Ms. Kalos holds a Master's of Science from University of Leicester and is a California licensed insurance agent. She is a regular speaker at regional, national and global Health & Wellness conferences, speaking recently in Russia on "Health & Wellness 2020," next generation health/wellness programs. Current speaking engagements include "Alzheimer's: Foresight is 2020".